Xilio Therapeutics, Inc.（XLO）内部人交易：高管与董事近期交易
过去 18 个月，共有 5 位内部人为 Xilio Therapeutics, Inc.（XLO）报告了 10 笔 Form 4 交易（最近一笔 2026-03-30）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-03-30 | Shannon James Samuel | 董事 | 买入 | 5,000 | $43,950 |
| 2026-01-05 | Russo Rene | PRESIDENT AND CEO | 买入 | 44,250 | $0 |
| 2026-01-05 | Luptakova Katarina | CHIEF MEDICAL OFFICER | 买入 | 16,625 | $0 |
| 2026-01-05 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | 买入 | 5,000 | $0 |
| 2026-01-05 | Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | 卖出 | 1,826 | $1,169 |
| 2026-01-05 | Frankenfield Christopher James | Chief Financial Officer | 买入 | 19,375 | $0 |
| 2026-01-05 | Frankenfield Christopher James | Chief Financial Officer | 卖出 | 7,030 | $4,499 |
| 2025-06-18 | Shannon James Samuel | 董事 | 买入 | 45,000 | $31,050 |
| 2025-06-18 | Shannon James Samuel | 董事 | 买入 | 25,000 | $17,250 |
| 2025-06-18 | Russo Rene | PRESIDENT AND CEO | 买入 | 36,289 | $24,677 |
来源：SEC Form 4 申报文件 · 截至 2026-03-30